Chronic hepatitis B with concurrent metabolic dysfunction-associated fatty liver disease: Challenges and perspectives
Clinical and Molecular Hepatology. 2023;29(2):320-331 
Dynamics of liver stiffness in chronic hepatitis B patients with concurrent metabolic-associated fatty liver disease
Journal of Hepatology. 2021;75(1):236-238
Metabolic dysfunction-associated fatty liver disease and chronic hepatitis B
Journal of the Formosan Medical Association. 2022;121(11):2148-2151
Validation of fatty liver index as a marker for metabolic dysfunction-associated fatty liver disease
. 2021;
Validation of Fatty Liver Index as a Marker for Metabolic Dysfunction-associated Fatty Liver Disease
. 2021;
Validation of Fatty Liver Index as a Marker for Metabolic Dysfunction-Associated Fatty Liver Disease
. 2021;
The Shift from nonalcoholic fatty liver disease to metabolic dysfunction–associated fatty liver disease
Clinical Liver Disease. 2022;20(5):157-161
Editorial: chronic hepatitis C with metabolic dysfunction‐associated fatty liver disease — a model for adoption of Sustainable Development Goal 3
Alimentary Pharmacology & Therapeutics. 2022;57(2):270-271
What the New Definition of Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Left Behind: Genetically Acquired Fatty Liver Disease (GAFLD)
eBioMedicine. 2021;72:103584
Metabolic dysfunction–associated fatty liver disease predicts new onset of chronic kidney disease better than fatty liver or nonalcoholic fatty liver disease
Nephrology Dialysis Transplantation. 2022;38(3):700-711